An open label six month study to evaluate the safety and efficacy of nitrogen mustard (NM) [chlormethine] 0.04% ointment formulation in patients with stage I or IIA mycosis fungoides (MF) who have completed an initial 12 month treatment with nitrogen mustard 0.02% but without a complete response.

Trial Profile

An open label six month study to evaluate the safety and efficacy of nitrogen mustard (NM) [chlormethine] 0.04% ointment formulation in patients with stage I or IIA mycosis fungoides (MF) who have completed an initial 12 month treatment with nitrogen mustard 0.02% but without a complete response.

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Jun 2014

At a glance

  • Drugs Chlormethine (Primary)
  • Indications Mycosis fungoides
  • Focus Therapeutic Use
  • Sponsors Actelion Pharmaceuticals
  • Most Recent Events

    • 06 Dec 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
    • 06 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 08 Nov 2010 Planned end date changed from 1 Mar 2011 to 1 Feb 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top